For Physicians. By Physicians.™
For Physicians. By Physicians.™
Payers of medical costs have used prior authorization (PA) for years to prevent unnecessary care and possible fraud. A survey conducted by the American Medical Association in 2018 revealed that over 90% of physicians found the practice unduly burdensome because of its negative impact on clinical outcome. 64% of physicians will wait at least one business day for prior authorization decisions and 30% will wait three business days or longer. 34% of physicians in a 2021 subsequent survey reported a PA led to a serious adverse event for a patient under their care.
Some payers require authorization for simple care such as generic medications. 30% of physicians claim PA programs are not based on evidence-based guidelines. A simple phone call can mushroom into a protracted back and forth that only delays a patient’s access to vital medical care. Physicians and their staff spend 13 hours per week on average completing PAs. e. Nearly 80% of physicians reported that patients will abandon a recommended course of care due to the preauthorization maze. In this age of health coverage contraction, patients have limited choices if they want to change health plans. Some suggestions for overhauling the authorization process include speeding up the adoption of electronic standards for prior authorization that will eliminate denials for non-clinical reasons, and employing professionals beyond physician offices who understand the language of medicine. Professional organizations have spoken out that “reducing administrative burden is a must” to not only reduce provider stress but, most importantly, improve patient outcomes.
AMA survey says prior authorizations hurting clinical outcomes
AMA: Why prior authorization is bad for patients and bad for business
AAFP: Reducing Administrative Burden a Must
Prior Authorization: Do Insurers Pay Bonuses for Denying New-Drug Requests?
Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants
Take a post-test and get CME credits
Please log in to ObGFirst to access the 2T US Atlas
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
